Health Care & Life Sciences » Biotechnology | Biotec Pharmacon ASA

Biotec Pharmacon ASA | Ownership

Companies that own Biotec Pharmacon ASA

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DNB Asset Management AS
259,112
0.54%
0
0%
07/31/2018
Storebrand Asset Management AS
178,741
0.37%
0
0%
08/31/2018

About Biotec Pharmacon ASA

View Profile
Address
Siva Innovasjonssenter
Tromsø TR 9019
Norway
Employees -
Website http://www.biotec.no
Updated 07/08/2019
Biotec Pharmacon ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. It operates through the Enzymes and Beta-Glucans segments. The Enzymes segment consists of sales revenues and operating expenses associated with the subsidiary ArcticZymes AS, which develops and markets recombinant enzymes for use in life science research, molecular diagnostics, and bio-manufacturing.